schliessen

Filtern

 

Bibliotheken

Cover Image

Additional reduction in blood pressure after cholesterol-lowering treatment by statins ( lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors ( enalapril or lisinopril)

Blood pressure (BP) reduction was compared between patients receiving angiotensin-converting enzyme inhibitors alone and patients receiving these medications plus statins after 3 months of dietary intervention. Although BP was similarly reduced at week 4, the statin-treated group had a greater reduc... Full description

Journal Title: The American journal of cardiology 1999, Vol.83 (10), p.1497-1499
Main Author: Spósito, Andrei C
Other Authors: Mansur, Antonio P , Coelho, Otavio R , Nicolau, Jose C , Ramires, Jose A.F
Format: Electronic Article Electronic Article
Language: English
Subjects:
Angiotensin-Converting Enzyme Inhibitors - therapeutic use
Anticholesteremic Agents - therapeutic use
Biological and medical sciences
Blood Pressure - drug effects
Cholesterol
Drug Interactions
Drug therapy
Enalapril - therapeutic use
Enzymes
Female
General and cellular metabolism. Vitamins
Heart Rate - drug effects
Humans
Hypercholesterolemia - complications
Hypercholesterolemia - drug therapy
Hypertension
Hypertension - complications
Lisinopril - therapeutic use
Lovastatin - therapeutic use
Male
Medical sciences
Middle Aged
Pharmacology. Drug treatments
Pravastatin - therapeutic use
Quelle: Alma/SFX Local Collection
Publisher: New York, NY: Elsevier Inc
ID: ISSN: 0002-9149
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_proquest_journals_230354210
title: Additional reduction in blood pressure after cholesterol-lowering treatment by statins ( lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors ( enalapril or lisinopril)
format: Article
creator:
  • Spósito, Andrei C
  • Mansur, Antonio P
  • Coelho, Otavio R
  • Nicolau, Jose C
  • Ramires, Jose A.F
subjects:
  • Angiotensin-Converting Enzyme Inhibitors - therapeutic use
  • Anticholesteremic Agents - therapeutic use
  • Biological and medical sciences
  • Blood Pressure - drug effects
  • Cholesterol
  • Drug Interactions
  • Drug therapy
  • Enalapril - therapeutic use
  • Enzymes
  • Female
  • General and cellular metabolism. Vitamins
  • Heart Rate - drug effects
  • Humans
  • Hypercholesterolemia - complications
  • Hypercholesterolemia - drug therapy
  • Hypertension
  • Hypertension - complications
  • Lisinopril - therapeutic use
  • Lovastatin - therapeutic use
  • Male
  • Medical sciences
  • Middle Aged
  • Pharmacology. Drug treatments
  • Pravastatin - therapeutic use
ispartof: The American journal of cardiology, 1999, Vol.83 (10), p.1497-1499
description: Blood pressure (BP) reduction was compared between patients receiving angiotensin-converting enzyme inhibitors alone and patients receiving these medications plus statins after 3 months of dietary intervention. Although BP was similarly reduced at week 4, the statin-treated group had a greater reduction in BP and total cholesterol levels at week 16, suggesting a synergistic effect between cholesterol lowering with statins and angiotensin-converting enzyme inhibitor treatment for hypertensive patients.
language: eng
source: Alma/SFX Local Collection
identifier: ISSN: 0002-9149
fulltext: fulltext
issn:
  • 0002-9149
  • 1879-1913
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK2.227556
LOCALfalse
PrimoNMBib
record
control
sourceidproquest_cross
recordidTN_cdi_proquest_journals_230354210
sourceformatXML
sourcesystemPC
sourcerecordid41868250
originalsourceidFETCH-LOGICAL-c408t-3ed5f24db80987c99a399df5a835b8ea3efb22fbd830d514ed51f5ee9f631dbd3
addsrcrecordideNqFkc1u1DAUhS0EotOBRwBZiEVnEbDjZBKrC1RV_EmVWABry7FvOq48drCdQcPD9lmwOwNUbLqKT3Lud098EHpByRtK6PrtV0JIXXHa8DPOV4RQVlfkEVrQvuMV5ZQ9Rou_lhN0GuNNlpS266fohBLG2q6jC3R7obVJxjtpcQA9q3LGxuHBeq_xFCDGOQCWY4KA1cZbiPnkbWX9TwjGXeMUQKYtuISHPY5JJuMiPsPW7-RBYR8ySP6Rq4Lf7CcI93CwNQpP-XPmRDzHApbu2vgELotKebeDkMprcL_2W8iQjRlM8qEsg5xfTsHYssuaPOGLWj1DT0ZpIzw_Ppfo-4f33y4_VVdfPn6-vLiqVEP6VDHQ7Vg3eugJ7zvFuWSc67GVPWuHHiSDcajrcdA9I7qlTbbTsQXg45pRPWi2RK8O3Cn4H3P-J3Hj55BDRVEzwtqmzle-RO3BpIKPMcAocsatDHtBiSilirtSRWlMcC7uShVl7uURPg9b0PemDi1mw-ujQUYl7RikUyb-83W8yRmy7fy__cqURrxLQRr7YIp3h2nI97gzEERUuS0F2gRQSWhvHiD8BuyQ2SE
sourcetypeAggregation Database
isCDItrue
recordtypearticle
pqid230354210
display
typearticle
titleAdditional reduction in blood pressure after cholesterol-lowering treatment by statins ( lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors ( enalapril or lisinopril)
sourceAlma/SFX Local Collection
creatorSpósito, Andrei C ; Mansur, Antonio P ; Coelho, Otavio R ; Nicolau, Jose C ; Ramires, Jose A.F
creatorcontribSpósito, Andrei C ; Mansur, Antonio P ; Coelho, Otavio R ; Nicolau, Jose C ; Ramires, Jose A.F
descriptionBlood pressure (BP) reduction was compared between patients receiving angiotensin-converting enzyme inhibitors alone and patients receiving these medications plus statins after 3 months of dietary intervention. Although BP was similarly reduced at week 4, the statin-treated group had a greater reduction in BP and total cholesterol levels at week 16, suggesting a synergistic effect between cholesterol lowering with statins and angiotensin-converting enzyme inhibitor treatment for hypertensive patients.
identifier
0ISSN: 0002-9149
1EISSN: 1879-1913
2DOI: 10.1016/S0002-9149(99)00132-0
3PMID: 10335771
4CODEN: AJCDAG
languageeng
publisherNew York, NY: Elsevier Inc
subjectAngiotensin-Converting Enzyme Inhibitors - therapeutic use ; Anticholesteremic Agents - therapeutic use ; Biological and medical sciences ; Blood Pressure - drug effects ; Cholesterol ; Drug Interactions ; Drug therapy ; Enalapril - therapeutic use ; Enzymes ; Female ; General and cellular metabolism. Vitamins ; Heart Rate - drug effects ; Humans ; Hypercholesterolemia - complications ; Hypercholesterolemia - drug therapy ; Hypertension ; Hypertension - complications ; Lisinopril - therapeutic use ; Lovastatin - therapeutic use ; Male ; Medical sciences ; Middle Aged ; Pharmacology. Drug treatments ; Pravastatin - therapeutic use
ispartofThe American journal of cardiology, 1999, Vol.83 (10), p.1497-1499
rights
01999 Excerpta Medica Inc.
11999 INIST-CNRS
2Copyright Elsevier Sequoia S.A. May 15, 1999
lds50peer_reviewed
citedbyFETCH-LOGICAL-c408t-3ed5f24db80987c99a399df5a835b8ea3efb22fbd830d514ed51f5ee9f631dbd3
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
thumbnail$$Usyndetics_thumb_exl
backlink
0$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1794035$$DView record in Pascal Francis
1$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10335771$$D View this record in MEDLINE/PubMed
search
creatorcontrib
0Spósito, Andrei C
1Mansur, Antonio P
2Coelho, Otavio R
3Nicolau, Jose C
4Ramires, Jose A.F
title
0Additional reduction in blood pressure after cholesterol-lowering treatment by statins ( lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors ( enalapril or lisinopril)
1The American journal of cardiology
addtitleAm J Cardiol
descriptionBlood pressure (BP) reduction was compared between patients receiving angiotensin-converting enzyme inhibitors alone and patients receiving these medications plus statins after 3 months of dietary intervention. Although BP was similarly reduced at week 4, the statin-treated group had a greater reduction in BP and total cholesterol levels at week 16, suggesting a synergistic effect between cholesterol lowering with statins and angiotensin-converting enzyme inhibitor treatment for hypertensive patients.
subject
0Angiotensin-Converting Enzyme Inhibitors - therapeutic use
1Anticholesteremic Agents - therapeutic use
2Biological and medical sciences
3Blood Pressure - drug effects
4Cholesterol
5Drug Interactions
6Drug therapy
7Enalapril - therapeutic use
8Enzymes
9Female
10General and cellular metabolism. Vitamins
11Heart Rate - drug effects
12Humans
13Hypercholesterolemia - complications
14Hypercholesterolemia - drug therapy
15Hypertension
16Hypertension - complications
17Lisinopril - therapeutic use
18Lovastatin - therapeutic use
19Male
20Medical sciences
21Middle Aged
22Pharmacology. Drug treatments
23Pravastatin - therapeutic use
issn
00002-9149
11879-1913
fulltexttrue
rsrctypearticle
creationdate1999
recordtypearticle
recordideNqFkc1u1DAUhS0EotOBRwBZiEVnEbDjZBKrC1RV_EmVWABry7FvOq48drCdQcPD9lmwOwNUbLqKT3Lud098EHpByRtK6PrtV0JIXXHa8DPOV4RQVlfkEVrQvuMV5ZQ9Rou_lhN0GuNNlpS266fohBLG2q6jC3R7obVJxjtpcQA9q3LGxuHBeq_xFCDGOQCWY4KA1cZbiPnkbWX9TwjGXeMUQKYtuISHPY5JJuMiPsPW7-RBYR8ySP6Rq4Lf7CcI93CwNQpP-XPmRDzHApbu2vgELotKebeDkMprcL_2W8iQjRlM8qEsg5xfTsHYssuaPOGLWj1DT0ZpIzw_Ppfo-4f33y4_VVdfPn6-vLiqVEP6VDHQ7Vg3eugJ7zvFuWSc67GVPWuHHiSDcajrcdA9I7qlTbbTsQXg45pRPWi2RK8O3Cn4H3P-J3Hj55BDRVEzwtqmzle-RO3BpIKPMcAocsatDHtBiSilirtSRWlMcC7uShVl7uURPg9b0PemDi1mw-ujQUYl7RikUyb-83W8yRmy7fy__cqURrxLQRr7YIp3h2nI97gzEERUuS0F2gRQSWhvHiD8BuyQ2SE
startdate1999
enddate1999
creator
0Spósito, Andrei C
1Mansur, Antonio P
2Coelho, Otavio R
3Nicolau, Jose C
4Ramires, Jose A.F
general
0Elsevier Inc
1Elsevier
2Elsevier Limited
scope
0IQODW
1CGR
2CUY
3CVF
4ECM
5EIF
6NPM
7AAYXX
8CITATION
97QO
107TS
118FD
12FR3
13K9.
14P64
sort
creationdate1999
titleAdditional reduction in blood pressure after cholesterol-lowering treatment by statins ( lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors ( enalapril or lisinopril)
authorSpósito, Andrei C ; Mansur, Antonio P ; Coelho, Otavio R ; Nicolau, Jose C ; Ramires, Jose A.F
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-c408t-3ed5f24db80987c99a399df5a835b8ea3efb22fbd830d514ed51f5ee9f631dbd3
rsrctypearticles
prefilterarticles
languageeng
creationdate1999
topic
0Angiotensin-Converting Enzyme Inhibitors - therapeutic use
1Anticholesteremic Agents - therapeutic use
2Biological and medical sciences
3Blood Pressure - drug effects
4Cholesterol
5Drug Interactions
6Drug therapy
7Enalapril - therapeutic use
8Enzymes
9Female
10General and cellular metabolism. Vitamins
11Heart Rate - drug effects
12Humans
13Hypercholesterolemia - complications
14Hypercholesterolemia - drug therapy
15Hypertension
16Hypertension - complications
17Lisinopril - therapeutic use
18Lovastatin - therapeutic use
19Male
20Medical sciences
21Middle Aged
22Pharmacology. Drug treatments
23Pravastatin - therapeutic use
toplevel
0peer_reviewed
1online_resources
creatorcontrib
0Spósito, Andrei C
1Mansur, Antonio P
2Coelho, Otavio R
3Nicolau, Jose C
4Ramires, Jose A.F
collection
0Pascal-Francis
1Medline
2MEDLINE
3MEDLINE (Ovid)
4MEDLINE
5MEDLINE
6PubMed
7CrossRef
8Biotechnology Research Abstracts
9Physical Education Index
10Technology Research Database
11Engineering Research Database
12ProQuest Health & Medical Complete (Alumni)
13Biotechnology and BioEngineering Abstracts
jtitleThe American journal of cardiology
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
au
0Spósito, Andrei C
1Mansur, Antonio P
2Coelho, Otavio R
3Nicolau, Jose C
4Ramires, Jose A.F
formatjournal
genrearticle
ristypeJOUR
atitleAdditional reduction in blood pressure after cholesterol-lowering treatment by statins ( lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors ( enalapril or lisinopril)
jtitleThe American journal of cardiology
addtitleAm J Cardiol
date1999
risdate1999
volume83
issue10
spage1497
epage1499
pages1497-1499
issn0002-9149
eissn1879-1913
codenAJCDAG
abstractBlood pressure (BP) reduction was compared between patients receiving angiotensin-converting enzyme inhibitors alone and patients receiving these medications plus statins after 3 months of dietary intervention. Although BP was similarly reduced at week 4, the statin-treated group had a greater reduction in BP and total cholesterol levels at week 16, suggesting a synergistic effect between cholesterol lowering with statins and angiotensin-converting enzyme inhibitor treatment for hypertensive patients.
copNew York, NY
pubElsevier Inc
pmid10335771
doi10.1016/S0002-9149(99)00132-0